Evidence map›Paper›PMID 20437069›Full record

ReviewMarine biotechnology (New York, N.Y.)2011

Culturability and secondary metabolite diversity of extreme microbes: expanding contribution of deep sea and deep-sea vent microbes to natural product discovery.

Robin K Pettit

Abstract readReview
PubMed Publisher
In one paragraph

Review in Marine biotechnology (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Article
  3. The Chemistry and Biology of the Tetrodotoxin Natural Product Family.Angewandte Chemie (International ed. in English) · 2025
    Review
  4. Article
  5. Review
  6. Marine bioactive peptides with anticancer potential, a narrative review.International journal of biochemistry and molecular biology · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Extreme EnvironmentInternational journal of microbiology · 2019
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Robin K PettitDepartment of Chemistry and Biochemistry, Arizona State University, Tempe, AZ 85287-2404, USA. robin.pettit@asu.edu
Arizona State University · US

Funding

Molecular Target Focused Discovery of Anticancer DrugsR01CA090441 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI PETTIT, GEORGE R · 2001 to 2010
$4.8M
Molecular Target Focused Discovery of Anticancer DrugsR56CA090441 · NCI · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI PETTIT, GEORGE R · 2007 to 2007
$498k
NCI NIH HHS 2R56 CA090441-06A1NCI NIH HHS 5R01 CA090441-07NCI NIH HHS R01 CA90441-01-05
6 · The paper itself

Abstract

Microbes from extreme environments do not necessarily require extreme culture conditions. Perhaps the most extreme environments known, deep-sea hydrothermal vent sites, support an incredible array of archaea, bacteria, and fungi, many of which have now been cultured. Microbes cultured from extreme environments have not disappointed in the natural products arena; diverse bioactive secondary metabolites have been isolated from cultured extreme-tolerant microbes, extremophiles, and deep-sea microbes. The contribution of vent microbes to our arsenal of natural products will likely grow, given the culturability of vent microbes; their metabolic, physiologic, and phylogenetic diversity; numerous reports of bioactive natural products from microbes inhabiting high acid, high temperature, or high pressure environments; and the recent isolation of new chroman derivatives and siderophores from deep-sea hydrothermal vent bacteria.

Indexed as

Adaptation, PhysiologicalArchaeaBacteriaBiological ProductsEcosystemFungiGeological PhenomenaHot TemperatureSeawaterBiological Products

Identifiers

PMID20437069
OpenAlexW2034226599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.